Our Journey
Our Milestones
Starting our operations since 1959 Torrent Pharma has crossed many milestones on the road to success.
Torrent Pharma’s Roadmap to Success
2024
- Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize its Novel Gastrointestinal Drug
- Commissioned a subsidiary in Colombia and Chile
2023
- Torrent and Zydus sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India
- Started construction of Virochannagar manufacturing facility
- Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility
2022
- Agreement with Dr. Reddy's Laboratories Ltd. to acquire four of its brands "Styptovit-E", "Finast", "Finast-T", and "Dynapress".
- Torrent Pharma enters into licensing agreement with Medicine Patent Pool to manufacture and commercialise generic version of Pfizer Oral COVID-19 Treatment
- Enters into co-marketing partnership with Boehringer Ingelheim India Private Limited to co-market its anti-diabetic drug and its fixed dose combinations in India
- Torrent Pharma acquires Curatio Healthcare to strengthen its presence in fast growing dermatology segment
2021
- Torrent Pharma Enters Into Voluntary Licensing Agreement with Lilly to manufacture and distribute Baricitinib for Covid-19 in India
- Torrent Pharma introduces MSD (a trade name of Merck & Co., Inc, Kenilworth, NJ, USA) and Ridgeback’s molnupiravir under the brand name Molnutor® in India
- Commissioned a subsidiary in Malta
2019
- Torrent & Glenmark sign licensing agreement for co-marketing of Remogliflozin Etabonate in India
- New manufacturing unit at Bileshwarpura set up to cater oncology formulations.
2018
- Acquired US based Bio-Pharm, Inc. (BPI)
2017
- Listed amongst top five ‘Fastest Growing Companies (Middleweights Category)’ by Business World Magazine
- Executive Chairman, listed by Business World Magazine, amongst India's Most Valuable CEOs in Large Category
- Acquired Women Healthcare brands from Novartis
- Acquired Unichem’s Domestic and Nepal business and also its Sikkim manufacturing facility.
2016
- Acquired API manufacturing Unit of Hyderabad based Glochem Industries Limited
2015
- Torrent Pharma recognized as the Most Promising Company of the Year at the 10th CNBC TV18 India Business Leader Awards 2014
- Torrent acquires 100% stake of Zyg Pharma
- Dahej Plant receives USFDA approval
2014
- Acquired Elder Pharma's identified Indian Branded Formulation Business in India and Nepal
- Launched Nephro, a dedicated division to cater to the Nephrology Segment
- Torrent Pharma's Dahej Plant commences operations
2013
- Torrent Pharma enters into a licensing agreement with Reliance Life Sciences for three biosimilars - Rituximab, Adalimumab, and Cetuximab
2012
- Indrad Plant awarded Sword of Honor for Occupational Health & Safety by British Safety Council
- Topical Foams system developed by Torrent Research Center
2011
- Sikkim Plant commences operation
- Indigenous Nasal Drug Delivery system developed by Torrent Research Center
- Set up Sparsh, a dedicated division to cater to Dermatology Segment
2010
- Baddi Plant received OHAS Audit 18001:2007 certification; facility approved by the regulatory authority of Uganda
- An advanced facility for Stability Studies set up at Indrad Plant
- Entered into the therapeutic area of Gynaecology
- Commenced commercial operations of Laboratories Torrent S.A. de C.V., Mexico
- Started construction of Dahej manufacturing facility
- Commissioned a subsidiary in United Kingdom and Romania
- Torrent Research Center develops Long Acting Injectables technology
- Foray into oncology segment
2009
- Commissioned dedicated formulation and packaging unit for manufacturing Insulin exclusively for Novo Nordisk
- Entered into license and supply agreement with AstraZeneca for marketing its products in international market
- Baddi Plant awarded Five Star rating by British Safety Council
2008
- Baddi Plant received GMP certification from Government of Upper Bavaria, Germany
2007
- Indrad Plant certified with ISO 9001: 2000 (Quality Management System), ISO 14001:2004 (Environmental Management System) and OHSAS 180001:1999 (Occupational Health and Safety Management System) by ISOQAR, UKAS accredited body
- Construction of Sikkim Plant started
2006
- The API and formulations manufacturing facilities located at Indrad (Gujarat, India) got US FDA approval
- Torrent Pharma and Pharma Dynamics (Pty) Ltd, South Africa signed a Technical Agreement for supplies of a range of products
2005
- New manufacturing unit at Baddi, Himachal Pradesh, set up to cater to domestic formulations market.
- Torrent Pharma signed an agreement with Novo Nordisk India to establish a new, dedicated formulation and packaging facility for Insulin, exclusively for Novo Nordisk.
- Acquired Heumann Pharma GmbH & Co Generica KG, a Pfizer group company, in Germany.
- Two new marketing divisions- AXON and NEURON set up to cater to neuropsychiatry segment.
- Entered into a research collaboration with AstraZeneca for developing novel anti-hypertensive drug.
- Torrent Pharma's QC department at Indrad manufacturing plant accredited with ISO/IEC- 17025 by NABL
2004
- Torrent Pharma's manufacturing facility at Indrad received MHRA (UK) and TGA (Australia) approvals
- Restructuring of marketing divisions and addition of new division, Delta.
- Torrent Australasia Pty Ltd. incorporated in Australia
2003
- Torrent Pharma Inc. set up in USA.
- GMP Certification received from European Union by Torrent Pharmaceuticals Manufacturing Plant
- Torrent Pharma Philippines Inc. set up.
2002
- Discovered and patented AGE (Advanced Glycosylation End-products) molecule.
- Torrent Pharma's Indrad Plant receives ISO 14001:1996 and OHSAS 18001:1999
- Torrent's R&D Centre received ISO/IEC 17025:1999 for its facilities by National Accreditation Board for Testing and Calibration Laboratories (NABL).
- Addition of a new marketing division, MIND
- Dual Retard Inlay Technology, Compact Tablet Technology, Gastro Retentive System and Multiparticulate / Matrix Based SR / Modified Release Formulations developed indigenously by Torrent Research Center (2002)
- Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award 2003 for both Formulations and API manufacturing facilities
- Brazilian Sanitary Surveillance Agency accredited Torrent's R&D Centre with ANVISA, authorizing it to conduct Bioequivalance Studies.
2001
- Torrent Pharma ranked in the top 10 Indian Companies in terms of Return on Capital Employed (ET - BCG Study Feb - 2001).
- Torrent Pharma bagged the 'Best Suppliers' award by the Sri Lankan State Pharmaceutical Corporation
- Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award for its Formulations facility and Silver Trophy for its API manufacturing facility
- Torrent do Brasil Ltda. set up in Brazil
2000
- Torrent Research Centre received OECD Standards of Good Lab. Practices Certificate from Dutch Health Ministry.
- Indrad Plant received ISO 9001:2000 Certificate
1999
- Restructuring of Torrent Pharma through formation of three new divisions – Prima, Vista, Psycan.
- First New Chemical Entity Patented by Torrent Research Center
- GCCI Export Appreciation Award
- Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award for its Formulations facility
1998
- Torrent Exports renamed as Torrent Ltd. as part of restructuring and consolidation exercise.
- Torrent Pharma acquires Pharma related investments and business of Torrent Exports Limited.
1996
- Shri U N Mehta bestowed with the title of Corporate Business Man of the Year
- State-of-the-art R&D Centre commissioned.
1995
- Torrent Gujarat Biotech Limited plant commissioned.
1992
- Torrent Pharma received IDMA Quality Excellence Award.
1990
- Torrent Exports Limited received National Export Award.
- Pride of Asia International award for excellence in Pharmaceuticals Products by international Friendship.
1989
- Second manufacturing plant commissioned at Indrad
- Torrent Exports Limited received Chemexcil Trishul Award for highest Pharma Exports.
- Torrent Pharma received IDMA Quality Excellence Award.
1988
- Torrent Laboratories Limited received Chemexcil Export Award.
1987
- Torrent Laboratories Limited received Chemexcil Export Award.
- Torrent Exports Limited received Export Award from Govt. of Gujarat.
1986
- Torrent Laboratories Limited received Chemexcil Export Award.
- Torrent Laboratories Limited received IDMA Quality Excellence Award.
- Torrent Exports Limited received Export Award from Govt. of Gujarat.
1985
- Torrent Laboratories Limited received IMC Golden Jubilee Endowment Award for Export Performance.
- Torrent Exports Limited received Export Award From Govt. of Gujarat.
- Torrent Laboratories Limited received IDMA Quality Excellence Award.
- Torrent Laboratories Limited received Chemexcil Export Award.
1984
- Torrent Laboratories Limited received Chemexcil Export Award.
- Torrent Laboratories Limited received Udyog Ratna Award.
1983
- Entry into the international markets. First Export order to USSR received
1980
- First manufacturing facility set up at Vatva in Ahmedabad
1971
- Trinity Laboratories renamed as Torrent Pharmaceuticals Limited.
1959
- Shri U. N. Mehta started Pharma operations.
